Cassava Sciences, Inc. - Common Stock (SAVA)

Cassava Sciences Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for neurodegenerative diseases, particularly Alzheimer's disease

The company aims to address unmet medical needs through its proprietary drug candidates, which are designed to enhance cognitive function and address the underlying biology of neurodegeneration. Cassava Sciences conducts rigorous research and clinical trials to advance its therapeutic solutions, with the vision of improving the quality of life for patients and their families affected by these challenging conditions.